Christopher Olopade to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Christopher Olopade has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.078
-
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol. JCO Glob Oncol. 2020 07; 6:983-990.
Score: 0.078
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.